1. Home
  2. SOS vs HBIO Comparison

SOS vs HBIO Comparison

Compare SOS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOS
  • HBIO
  • Stock Information
  • Founded
  • SOS 2004
  • HBIO 1901
  • Country
  • SOS China
  • HBIO United States
  • Employees
  • SOS N/A
  • HBIO N/A
  • Industry
  • SOS Finance: Consumer Services
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • SOS Finance
  • HBIO Industrials
  • Exchange
  • SOS Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • SOS 19.3M
  • HBIO 22.5M
  • IPO Year
  • SOS 2017
  • HBIO 2000
  • Fundamental
  • Price
  • SOS $5.58
  • HBIO $0.51
  • Analyst Decision
  • SOS
  • HBIO Buy
  • Analyst Count
  • SOS 0
  • HBIO 2
  • Target Price
  • SOS N/A
  • HBIO $3.00
  • AVG Volume (30 Days)
  • SOS 11.6K
  • HBIO 3.9M
  • Earning Date
  • SOS 05-15-2025
  • HBIO 08-07-2025
  • Dividend Yield
  • SOS N/A
  • HBIO N/A
  • EPS Growth
  • SOS N/A
  • HBIO N/A
  • EPS
  • SOS N/A
  • HBIO N/A
  • Revenue
  • SOS $231,424,000.00
  • HBIO $91,397,000.00
  • Revenue This Year
  • SOS N/A
  • HBIO N/A
  • Revenue Next Year
  • SOS N/A
  • HBIO $9.75
  • P/E Ratio
  • SOS N/A
  • HBIO N/A
  • Revenue Growth
  • SOS 150.42
  • HBIO N/A
  • 52 Week Low
  • SOS $4.04
  • HBIO $0.28
  • 52 Week High
  • SOS $15.51
  • HBIO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • SOS 44.27
  • HBIO 54.14
  • Support Level
  • SOS $5.51
  • HBIO $0.47
  • Resistance Level
  • SOS $5.90
  • HBIO $0.55
  • Average True Range (ATR)
  • SOS 0.23
  • HBIO 0.07
  • MACD
  • SOS -0.11
  • HBIO -0.00
  • Stochastic Oscillator
  • SOS 12.12
  • HBIO 50.68

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: